Altered activity profile of a tertiary silanol analog of multi-targeting nuclear receptor modulator T0901317

Bioorganic & Medicinal Chemistry Letters
2016.0

Abstract

We report the design, synthesis, and physicochemical/biological evaluation of novel silanol derivative 6 (sila-T) as a silanol analog of multi-target nuclear receptor modulator T0901317 (5). Compound 6 showed intermediate hydrophobicity between the corresponding alcohol 13 and perfluoroalcohol 5. While 5 exhibited potent activities toward liver X receptor α and β, farnesoid X receptor, pregnane X receptor (PXR) and retinoic acid receptor-related orphan receptor (ROR)γ, silanol 6 exhibited activity only toward PXR and RORs. Incorporation of silanol instead of perfluoroalcohol is a promising option for developing novel target-selective, biologically active compounds.

Knowledge Graph

Similar Paper

Altered activity profile of a tertiary silanol analog of multi-targeting nuclear receptor modulator T0901317
Bioorganic & Medicinal Chemistry Letters 2016.0
Design, synthesis and structure–activity relationship of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxyisoprop-2-yl)phenylsilane derivatives as liver X receptor agonists
Bioorganic & Medicinal Chemistry 2022.0
Development of novel silanol-based human pregnane X receptor (PXR) agonists with improved receptor selectivity
Bioorganic & Medicinal Chemistry 2018.0
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc
Bioorganic & Medicinal Chemistry Letters 2013.0
Design and synthesis of silicon-containing fatty acid amide derivatives as novel peroxisome proliferator-activated receptor (PPAR) agonists
Bioorganic & Medicinal Chemistry Letters 2015.0
Discovery and optimization of a novel series of liver X receptor-α agonists
Bioorganic & Medicinal Chemistry Letters 2006.0
Synthesis and evaluation of anilinohexafluoroisopropanols as activators/modulators of LXRα and β
Bioorganic & Medicinal Chemistry Letters 2006.0
Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity
Bioorganic & Medicinal Chemistry Letters 2018.0
Identification of a lead pharmacophore for the development of potent nuclear receptor modulators as anticancer and X syndrome disease therapeutic agents
Bioorganic & Medicinal Chemistry Letters 2006.0
Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor β-selective agonists
Bioorganic & Medicinal Chemistry Letters 2015.0